Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic (Q38084050)

28 August 2017

Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic (English)

1 reference

28 August 2017

0 references

Clostridium difficile

0 references

author name string

M Hell

1

1 reference

28 August 2017

C Bernhofer

2

1 reference

28 August 2017

P Stalzer

3

1 reference

28 August 2017

J M Kern

4

1 reference

28 August 2017

E Claassen

5

1 reference

28 August 2017

1 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

4

1 reference

28 August 2017

39-51

1 reference

28 August 2017

1

1 reference

Alternative strategies for Clostridium difficile infection

28 August 2017

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Let's go mucosal: communication on slippery ground

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

The emergence of 'hypervirulence' in Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Health benefits of probiotics: are mixtures more effective than single strains?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

The effects of commensal microbiota on immune cell subsets and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Biodiversity, ecological determinants, and metabolic exploitation of sourdough microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Exposure to environmental microorganisms and childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Toll-like receptors--novel targets in allergic airway disease (probiotics, friends and relatives).

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Recommendations for probiotic use-2011 update

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

INTESTINAL FLORA IN NEW-BORN INFANTS

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Inhibition and redistribution of NHE3, the apical Na+/H+ exchanger, by Clostridium difficile toxin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Clostridium difficile infection: monoclonal or polyclonal genesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

A Bifidobacterium probiotic strain and its soluble factors alleviate chloride secretion by human intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Infectious diarrhea: Cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Neuropathological alteration of aquaporin 1 immunoreactive enteric neurons in the streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Probiotics for the prevention and treatment of Clostridium difficile in older patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Probiotics in the gastrointestinal diseases of the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Transcriptional regulation of the intestinal luminal Na⁺ and Cl⁻ transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Emerging therapies for Clostridium difficile infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Lactic acid increases aquaporin 4 expression on the cell membrane of cultured rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Probiotic, prebiotic, and synbiotic use in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Clostridium difficile colitis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Antimicrobial peptides: old molecules with new ideas

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Recent advances in gut nutrient chemosensing

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Escherichia coli-induced epithelial hyporesponsiveness to secretagogues is associated with altered CFTR localization

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Aquaporin-4 in brain and spinal cord oedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Unraveling mechanisms of action of probiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

LPA stimulates intestinal DRA gene transcription via LPA2 receptor, PI3K/AKT, and c-Fos-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Up-regulation of intestinal type 1 taste receptor 3 and sodium glucose luminal transporter-1 expression and increased sucrose intake in mice lacking gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Clostridium difficile: novel insights on an incessantly challenging disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Regulation of tight junction permeability by intestinal bacteria and dietary components

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Role of regulatory T cells in gastrointestinal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Immunomodulation by genetically engineered lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Use of probiotics in gastrointestinal disorders: what to recommend?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Meta-analysis: probiotics in antibiotic-associated diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Immunomodulatory mechanisms of lactobacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0049

21 January 2018

Identifiers

DOI

10.3920/BM2012.0049

1 reference

28 August 2017

1 reference